Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Celgene Corporation    CELG

CELGENE CORPORATION (CELG)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Celgene Corporation
Develops human pharmaceuticals and agrochemicals

Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases.

Its targeting areas include intracellular signaling pathways, protein homeostasis and epigenetics in cancer and immune cells, immunomodulation in cancer and autoimmune diseases and therapeutic application of cell therapies.

The company's products include Revlimid, Vidaza, Thalomid, Pomalyst/Imnovid, Abraxane, and Istodax.

Celgene was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.

Number of employees : 7 467 persons.
Sales per Businesses
20162017Delta
USD (in Million)%USD (in Million)%
REVLIMID6,97463.8%8,18763.9% +17.4%
POMALYST/IMNOVID1,31112%1,61412.6% +23.14%
OTEZLA1,0179.3%1,27910% +25.74%
ABRAXANE973.408.9%992.007.7% +1.91%
VIDAZA608.005.6%628.004.9% +3.29%
THALOMID152.101.4%132.001% -13.21%
ISTODAX79.300.7%76.000.6% -4.16%
Azacitidine for Injection66.000.6%36.000.3% -45.45%
Other Revenue44.600.4%---
Other4.300%39.000.3% +806.98%
IDHIFA--20.000.2%-
Sales per Regions
20162017Delta
USD (in Million)%USD (in Million)%
United States7,01064.2%8,32464.9% +18.75%
Europe3,04627.9%3,32725.9% +9.21%
All Other1,17310.7%1,35210.5% +15.23%
Managers
NameAgeSinceTitle
Mark Alles592004Chairman & Chief Executive Officer
Scott Andrew Smith562008President & Chief Operating Officer
Peter N. Kellogg, MBA622014Executive VP, Chief Financial & Accounting Officer
Joseph S. Camardo, MD63-Senior Vice President-Global Medical Affairs
Rupert J. Vessey, PhD532015President-Research & Early Development
Gilla Kaplan, PhD711998Independent Director
Michael D. Casey722002Lead Independent Director
James J. Loughlin, CPA752007Independent Director
Ernest Mario, PhD802007Independent Director
Carrie Smith Cox612009Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 964,575,608 750,084,143 77.8% 212,400,000 22.0% 77.8%
Shareholders
NameEquities%
The Vanguard Group, Inc. 54,244,805 6.89%
BlackRock Fund Advisors 41,467,782 5.27%
SSgA Funds Management, Inc. 32,175,605 4.09%
Fidelity Management & Research Co. 12,110,724 1.54%
Edgewood Management LLC 11,533,492 1.46%
Northern Trust Investments, Inc. 10,421,367 1.32%
Henderson Global Investors Ltd. 10,056,957 1.28%
Deutsche Asset Management Investment GmbH 10,035,932 1.27%
Jennison Associates LLC 9,815,811 1.25%
Geode Capital Management LLC 8,308,096 1.06%
Holdings
NameEquities%Valuation
Juno Therapeutics Inc (JUNO) 11,109,1609.73%953,277,020 USD
Agios Pharmaceuticals Inc (AGIO) 6,093,85810.7%479,952,256 USD
BEIGENE LTD COM 32,746,41610.4%341,845,731 USD
Acceleron Pharma Inc (XLRN) 6,118,47913.5%253,978,063 USD
Crispr Therapeutics AG (CRSP) 2,800,7725.97%110,014,324 USD
Epizyme Inc (EPZM) 3,674,6405.30%59,345,436 USD
Zymeworks Inc (ZYME) 1,539,4836.07%20,305,781 USD
Mesoblast limited (MSB) 15,453,8913.27%16,768,554 USD
Oncomed Pharmaceuticals Inc (OMED) 2,970,5887.85%7,426,470 USD
Alliqua Biomedical Inc (ALQA) 804,61016.1%1,713,015 USD
Markets and indexes
- Nasdaq Stock Market
- Nasdaq Global Select Market
- Nasdaq 100 / SP 100, SP 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Stock Exchange Codes
- Bloomberg Code :  CELG:US
- Reuters Code :  CELG.O
- Datastream Code :  
Company contact information
Celgene Corporation
86 avenue Morris
NJ 07901 Summit, New Jersey
États-Unis (les)

Phone : +1 908 673 9000
Fax : +1
Internet : http://www.celgene.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
CELGENE CORPORATION-10.14%70 622
JOHNSON & JOHNSON-7.02%349 006
NOVARTIS-2.94%224 221
PFIZER-1.33%213 155
ROCHE HOLDING LTD.-9.41%207 327
MERCK AND COMPANY-3.02%148 618
AMGEN4.92%132 428
BRISTOL-MYERS SQUIBB COMPANY7.60%108 890
ABBOTT LABORATORIES3.36%102 678
NOVO NORDISK A/S-4.17%101 783
SANOFI-9.46%100 822
BAYER-5.85%100 123
GLAXOSMITHKLINE-2.00%91 577
ELI LILLY AND COMPANY-8.61%85 390
ASTRAZENECA-7.21%85 057
ALLERGAN PLC-2.56%53 014
TAKEDA PHARMACEUTICAL CO LTD-8.37%43 486
SHIRE-22.46%38 453
JIANGSU HENGRUI MEDICINE CO LTD5.06%32 137
ASTELLAS PHARMA INC5.38%29 158
CHUGAI PHARMACEUTICAL CO LTD-6.59%28 437
Connections : Celgene Corporation
Receptos, Inc.
Taxis Pharmaceuticals, Inc.
Mali Health Organizing Project
American College of Physicians Foundation
Rosemont College
European Federation of Pharmaceutical Industries & Assns
GNS Healthcare, Inc.
Pharmaceutical Research & Manufacturers of America
Rutgers University Foundation
Orbus Therapeutics, Inc.
Biotechnology Innovation Organization
HealthCare Institute of New Jersey
Gilda's Club New York City
Desmond Tutu Hiv Foundation
Gladstone Foundation (CA)
Bill & Melinda Gates Foundation Trust
Humacyte, Inc.
PharmAkea, Inc.
Sidecar Therapeutics, Inc.
University of Pennsylvania Museum of Archaeology & Anthropolog
© 2018 People , Fundamentals and Ownership    © 2018 Cofisem